Qure.ai: Improving Early Lung Cancer Detection Through AI-Powered Solutions with Ranjana Devi and Waqas Haque, MD, MPH

This installment of Oncology Data Advisor’s Exploring Artificial Intelligence (AI) in Oncology series features a discussion recorded live at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting between Ranjana Devi, Vice President of Product Development, Oncology, at Qure.ai, and Fellows Forum member Dr. Waqas Haque.

Check out the episode to hear more about:

  • Qure.ai’s mission of making healthcare more accessible and equitable to patients worldwide through innovations in deep learning and AI
  • Current challenges in lung cancer screening and the capabilities of AI in addressing these gaps
  • Qure.ai’s end-to-end AI-powered solutions for early lung cancer detection and care
  • The efficacy of these solutions and how they can be used in the clinic
  • The lung cancer portfolio that Qure.ai showcased at ASCO
  • Other innovations coming down the pipeline
  • And more!

About the Speakers

Ranjana Devi is the Vice President of Product Development, Oncology, at Qure.ai. She is based out of the HQ in Mumbai, India and frequently travels to the Qure.ai offices in New York and London, plus attends international conferences to showcase Qure.ai’s innovations. She has a background in engineering, having studied at the Indian Institute of Technology in Bombay, and is passionate about building a better future through AI-powered products in healthcare.  

Waqas Haque, MD, MPH, is an Incoming Hematology/Oncology Fellow at the University of Chicago. He is currently finishing up his Internal Medicine Residency in a Clinical Investigator Track at New York University. Dr. Haque balances his patient care work with a variety of research projects. During his fellowship training at the University of Chicago, he plans to further his work in innovative clinical trial design, value-based care delivery to cancer patients, and clinical investigation. He is a recipient of the 40 Under 40 in Cancer Award, which recognizes the contributions of rising stars and emerging leaders across the field of oncology.

For More Information

Qure.ai (2024). Available at: https://www.qure.ai/

Banner ad

Related Articles


Your email address will not be published. Required fields are marked *